Hyaluronic Acid
Market Insights
The Hyaluronic Acid market is projected to grow at a CAGR
of 8.82% during the forecast period. The market is estimated to generate
revenue of USD 16.2 Billion by 2026. Extensive use of hyaluronic acid in
dermatology is expected to have a positive impact on the market. This growth
can be attributed to growing number of people opting for aesthetic non-surgical
procedures and growing geriatric population.
Rising disposable income of individuals has led to
consumers spending more on aesthetic non-surgical procedures such as hyaluronic
acid injections. Factors such as high cost of the procedure and side-affects
associated with hyaluronic acid are some factors expected to hinder the market
up to a certain extent.
Request for a
free sample copy of this
report @:
Hyaluronic Acid
Market: By Application
The Hyaluronic Acid market can be segmented based on basis
of application into dermal fillers, osteoarthritis, ophthalmic and
vesicoureteral reflux among others. The osteoarthritis segment can be segmented
further into single injection, three injections and five injections among
others. The dermal fillers segment is expected to hold the largest market share
in terms of revenue during the forecast period. Desire to look healthy and
young and high effectiveness of dermal fillers is inclining men and women to
opt for this procedure.
The osteoarthritis segment is also expected to grow at a
substantial CAGR. Within the segment, the three injection segment is projected
to hold the largest market share in terms of revenue, while the single
injection segment is expected to grow at the highest CAGR. The ophthalmic
applications segment is expected to grow at the fastest rate owing to growing
incidence of cataract, glaucoma, dry eyes and age-related macular
degeneration.
Hyaluronic Acid
Market: Regional Insights
North America is expected to dominate the hyaluronic acid
market, with U.S. being the major contributor. High disposable income of the
population and their awareness about aging is expected to drive the market in
the region. The Asia Pacific region is projected to register high growth rate
in the coming years. Japan is expected to contribute a major share to the
growth in Asia Pacific region due to its high geriatric population.
Hyaluronic Acid
Market: End-Use Landscape
The end-use landscape entails a list of current and
prospective consumers prevailing across the regions. This section provides
company addresses, contact details, products, and regional presence of
companies who are purchasing or are likely to purchase hyaluronic acid over the
coming years. Some companies which are currently using hyaluronic acid and are
likely to purchase it in future such as Shiseido, Proctor & Gamble Co and
Unilever among others.
Hyaluronic Acid
Market: Vendor Landscape
The report contains a chapter
dedicated to vendors operating in the market, covering raw material
manufactures, equipment developers, manufacturers, and distributors. The report
provides these insights on a regional level. This section of the report entails
contact details, experience, products manufactured/supplied, and geographical
presence of companies.
Hyaluronic Acid
Market: Share & Competitor
Analysis
Some of the key players operating in the Hyaluronic Acid
market are Kikkoman,
Allergan, Inc.; Sanofi (Genzyme); Salix Pharmaceuticals; Seikagaku
Corporation; Galderma S.A., Zimmer Holdings, Inc.; Smith & Nephew Plc;
Ferring Pharmaceuticals, Inc.; Anika Therapeutics, Inc.; and F. Hoffmann-La
Roche Ltd.
In 2016, Genzyme Corporation received
FDA approval for its single injection treatment. Presence of high-molecular
weight polymers of hyaluronic acid in the product are used as a lubricant to
reduce the pain caused by osteoarthritis.
In March 2016, Anika Therapeutics launched its
viscosupplement Cignal which is a combination of viscosupplement and steroids
that help alleviate knee pain
In 2015, Actavis acquired Allegran, which a manufacturer of
hyarulonic acid based ophthalmic dermatologic and aesthetic products.
No comments:
Post a Comment